Lv1
38 积分 2025-07-07 加入
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3天前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3天前
已完结
Ototoxicity and Teprotumumab
7天前
已完结
Low clinical activity score, ‘progressive’ thyroid eye disease: presentations of 1439 patients from a tertiary centre in Hong Kong
1个月前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
1个月前
已完结
Mechanisms in Thyroid Eye Disease: The TSH Receptor Interacts Directly With the IGF-1 Receptor
2个月前
已完结
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
3个月前
已完结
Effect of glucagon on renal excretion of oxypurinol and purine bases
4个月前
已关闭
Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
5个月前
已完结
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
6个月前
已完结
皖公网安备34019202002308
